Azathioprine has been approved in the European Union and in the Other Countries

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.


azathioprine studies

Select the study ID number to view the trial summary

Study IDPhaseTitle
IMU40001 / AZAF 1002 IV A randomised, single-dose, three-way cross-over study evaluating the bioequivalence of 50 mg oral doses of the azathioprine formulation manufactured in Germany compared to the azathioprine formulations manufactured in France and UK in healthy volunteers.